ESMO Breast Cancer 2025: Abstracts
The abstract submission will open soon!
The abstract submission will open soon!
The fellowship provides a two-year grant of $130,000 to support the salary and benefits of the fellow while working on a mentored brain cancer research…
Take this survey powered by surveymonkey.com. Create your own surveys for free.
Since the addition of rituximab to CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone), major advances in first-line therapy of large B-cell
Research and Education Fund Tiered Giving The Research and Education Fund (REF) Tiered Giving Program recognizes donors whose contributions since 2014 have collectively advanced cancer…
Experts examine both overall survival outcomes and independent review committeeāassessed progression-free survival data from the AMPLIFY trial.
Efficacy findings from a phase 2 trial demonstrated that abenacianine visualized lung tumor tissue and was well tolerated when used during surgery.
The prevalence of metabolic syndrome among adult survivors of childhood cancer is higher compared to a noncancer control population. Therapeutic exposures and lifestyle factors are…
Study results āprovide strong support for integrating symptom screening and care pathways into routine clinical care,ā according to researchers
An abstract is unavailable.
Click on the article title to read more.